Filing Details
- Accession Number:
- 0000899243-19-005889
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 18:58:32
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 18:58:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1613498 | Jon Snodgres | C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-28 | 5,922 | $0.00 | 26,821 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-02-28 | 1,875 | $58.88 | 24,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-02-28 | 5,653 | $0.00 | 5,653 | $59.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,653 | 2029-02-28 | No | 4 | A | Direct |
Footnotes
- Mr. Snodgres was awarded 5,922 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- Sale of 1,875 shares in the open market to cover tax liability resulting from the release of restricted stock units.
- $58.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.09 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.
Billionaire Hedge Funds
